Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study

医学 二甲双胍 2型糖尿病 糖尿病 队列 内科学 队列研究 胰岛素 观察研究 内分泌学
作者
Alexander Kutz,Dae Hyun Kim,Jun Liu,Medha Munshi,Elisabetta Patorno
出处
期刊:Diabetes Care [American Diabetes Association]
卷期号:48 (3): 455-463 被引量:1
标识
DOI:10.2337/dc24-1795
摘要

OBJECTIVE To assess prescribing trends of glucose-lowering medications in the last year of life among older adults with type 2 diabetes (T2D) and explore whether frailty is associated with differential prescribing. RESEARCH DESIGN AND METHODS In this observational cohort study of Medicare beneficiaries aged ≥67 years (2015–2019) with T2D, we assessed temporal trends in prescribing a glucose-lowering medication, stratified by frailty. The main outcome included glucose-lowering medication fills within 1 year of death. RESULTS Among 975,407 community-dwelling Medicare beneficiaries with T2D, the use of glucose-lowering medications within 1 year of death slightly increased from 71.4% during the first 6-month period in 2015 to 72.9% (standardized mean difference [SMD] −0.03) during the second 6-month period in 2019. The most pronounced increase in use was observed for metformin (40.7% to 46.5%, SMD −0.12), whereas the largest decrease was observed for sulfonylureas (37.0% to 31.8%, SMD 0.11). Overall glucose-lowering medication use decreased from 66.1% in the 9 to 12 months before death to 60.8% in the last 4 months of life (SMD 0.11; P < 0.01), driven by reduced noninsulin medication use. The use of short-acting and long-acting insulin both increased near death, with frailer individuals more likely to receive insulin. Sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists, although less common, became more frequent in more recent years. CONCLUSIONS The use of glucose-lowering medications declined in the last year of life, mainly due to reduced noninsulin use. Insulin use increased near death, particularly among frailer individuals, highlighting the need for careful end-of-life management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
阿南发布了新的文献求助30
2秒前
2秒前
3秒前
领导范儿的应助被池载岸采纳,获得10
4秒前
陈美美发布了新的文献求助10
5秒前
在水一方的应助被油面摊子采纳,获得10
5秒前
YuLu发布了新的文献求助10
5秒前
6秒前
6秒前
羲成发布了新的文献求助10
7秒前
慕青的应助被刘刘刘医生采纳,获得10
7秒前
JamesPei的应助被Lea采纳,获得10
7秒前
超级拉瓦锡完成签到,获得积分10
7秒前
9秒前
糊涂的雪珊完成签到,获得积分10
9秒前
南瓜好吃完成签到 ,获得积分10
10秒前
Eli发布了新的文献求助10
10秒前
脑洞疼的应助被黄毛虎采纳,获得10
10秒前
lq完成签到,获得积分10
11秒前
11秒前
正直未来完成签到,获得积分10
11秒前
王珂发布了新的文献求助10
12秒前
14秒前
15秒前
18秒前
19秒前
ddddd发布了新的文献求助10
19秒前
油面摊子发布了新的文献求助10
19秒前
方法完成签到,获得积分10
19秒前
李明完成签到,获得积分10
20秒前
李健的小迷弟的应助被Eli采纳,获得10
21秒前
读树完成签到 ,获得积分10
21秒前
初一发布了新的文献求助10
22秒前
共享精神的应助被云一采纳,获得10
22秒前
李爱国的应助被liu采纳,获得10
24秒前
yue完成签到,获得积分10
25秒前
qikuu发布了新的文献求助30
25秒前
华仔的应助被上杉绘梨衣采纳,获得10
25秒前
声声发布了新的文献求助10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186875
求助须知:如何正确求助?哪些是违规求助? 9575211
关于积分的说明 21840004
捐赠科研通 7784592
什么是DOI,文献DOI怎么找? 3434866
关于科研通互助平台的介绍 2559266
邀请新用户注册赠送积分活动 2481717